Study for theraputic effect of soy been peptide on arthritis in patients with rheumatoid arthritis.

Study for theraputic effect of soy been peptide on arthritis in patients with rheumatoid arthritis. - Effect of soy been peptide on rheumatoid arthritis.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000021633

Enrollment

Registered

2016-03-27

Start date

2014-06-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid arthritis

Interventions

Patients with rheumatoid arthritis were orally treated with the soy been peptide (8g/day) for 8 weeks. Patients with rheumatoid arthritis were orally treated with the placebo (8g/day) for 8 weeks.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Out patients with rheumatoid arthritis.

Exclusion criteria

Exclusion criteria: Patients with malignant diseases, or other severe diseases, hospitalaized patients.

Design outcomes

Primary

Measure	Time frame
Theraputic effects of soy been peptide on tender joints and swollen joints in rheumatoid arthritis, anti-pain effect	—

Secondary

Measure	Time frame
inhibitory effect of inflammation	—

Countries

Japan

Contacts

Public Contactkazuo Yudo

St. Marianna University School of Medicine Institute of Medical Science

yudo@marianna-u.ac.jp0449778111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026